A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is
Mortality and Costs of Acute Renal Failure Associated with Amphotericin B Therapy
Clinical Infectious Diseases
To assess the mortality and resource utilization that results from acute renal failure associated with amphotericin B therapy, 707 adult admissions in which parenteral amphotericin B therapy was given were studied at a tertiary-care hospital. Main outcome measures were mortality, length of stay, and costs; we controlled for potential confounders, including age, sex, insurance status, baseline creatinine level, length of stay before beginning amphotericin B therapy, and severity of illness.doi:10.1086/319211 pmid:11229835 fatcat:wjlanzyhtfbczne6yld6yduzoa